4
Changes in Ownership
Seres Therapeutics, Inc. Filed Acc 0001209191-15-057204
Director acquired 11,627,320 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
AFEYAN NOUBAR · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2015-06-26 | Conversion : show line 1 in the form | +8,822,420 | 8,822,420 | I |
| 2015-06-26 | Conversion : show line 2 in the form | +2,205,603 | 2,205,603 | I |
| 2015-06-26 | Conversion : show line 3 in the form | +599,297 | 599,297 | I |
Table II: Derivative
8 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2015-06-26 | Conversion : show line 4 in the form Series A Convertible Preferred Stock | −6,105,362 | 6,105,362 | 0 | I | ||
| 2015-06-26 | Conversion : show line 5 in the form Series A Convertible Preferred Stock | −1,526,338 | 1,526,338 | 0 | I | ||
| 2015-06-26 | Conversion : show line 6 in the form Series A Convertible Preferred Stock | −599,297 | 599,297 | 0 | I | ||
| 2015-06-26 | Conversion : show line 7 in the form Series A-2 Convertible Preferred Stock | −898,877 | 898,877 | 0 | I | ||
| 2015-06-26 | Conversion : show line 8 in the form Series A-2 Convertible Preferred Stock | −224,719 | 224,719 | 0 | I | ||
| 2015-06-26 | Conversion : show line 9 in the form Series B Convertible Preferred Stock | −1,818,181 | 1,818,181 | 0 | I | ||
| 2015-06-26 | Conversion : show line 10 in the form Series B Convertible Preferred Stock | −454,546 | 454,546 | 0 | I | ||
| 2015-06-25 | Grant or award : show line 11 in the form Stock Option (right to buy) | +15,000 | $18.00 | 2025-06-24 | 15,000 | 15,000 | I |
Loading xslF345X03/doc4.xml…